Answers are grounded in this paper and cite their sources.
The increase in the infections caused by multi-, extended-, and pandrug-resistant bacteria that we are facing in the last decades represent an important global health threat. 1 When we talk about multidrug-resistant (MDR) bacteria, two issues should be taken into consideration: (1) the emergence of MDR microorganisms and (2) their further spread. The driving factors behind the emergence of MDR bacteria include the use and, in addition, the abuse of antibiotics in different settings such as the veterinary, the community, and the health-care centers. Likewise, the main factors contributing to their spread at a global level comprise migrant birds, globalization of commercial food, and international traveling. The current scenario of MDR bacteria is led by Enterobacteriaceae , mainly those producing extended-spectrum β-lactamases (ESBLs) and/or carbapenemases. Travelers to developing countries certainly play an important role by acquiring and harboring MDR bacteria in their gut microbiota, which are further carried during their travels and are finally introduced into their home countries. In a study 2 performed by our group, fecal carriage of ESBL-producing Escherichia coli strains was found among 17.9% of Spanish travelers returning from tropical or subtropical countries, with CTX-M-15 being the most prevalent enzyme (80%). When these data were stratified according to the countries of destination, a higher prevalence of fecal carriers of ESBL was found among patients visiting the Asian continent (29.2%), which further increased to 37.4% for those travelers returning from India. 2 Traveling to areas and countries with a high endemicity of MDR bacteria should therefore be considered a risk factor of MDR carriage, at least up to the first 3 months after return. 3 In a recently published study, Kantele and colleagues 4 screened the presence of ESBL- and/or carbapenemase-producing Enterobacteriaceae in stool samples from Finnish travelers outside Scandinavia. They found that 21% of the 430 surveyed travelers became colonized by ESBL-producing Enterobacteriaceae and they did not find any carbapenemase-producing Enterobacteriaceae . It is worthy of mention that geographic region, occurrence of travelers' diarrhea (TD), age, and use of antibacterial agents for TD were found to be independent risk factors predisposing to contracting ESBL-producing Enterobacteriaceae . Moreover, in the subgroup of travelers in South Asia, the colonization rate was 23% overall but reached 47% in cases of TD and 80% in cases of TD treated with antibiotics. In a study published within this issue, Epelboin and colleagues 5 have evaluated the risk factors for carrying MDR Gram-negative bacilli among returning travelers without history of hospitalization abroad and admitted at the Department of Infectious and Tropical Diseases in the Hospital Pitié Salpêtrière in Paris, France. This group was compared to non-travelers. It was observed that either carriage or infections caused by MDR Gram-negative bacilli were significantly more frequent in travelers (11.0% in travelers vs 1.2% in non-travelers). The authors also found that both carriage and infection by MDR Gram-negative bacilli were significantly more common in travelers visiting friends and relatives or migrants and in those receiving chemoprophylaxis against malaria, which is in good agreement with results from another study suggesting a possible association between malaria chemoprophylaxis with doxycycline and an increased risk of MDR Enterobacteriaceae among military personnel in the United States and Afghanistan. 6 While this is an interesting hypothesis, it needs further validation as the authors were missing data regarding the use of drugs for malaria prophylaxis, and previous studies have also shown that the use of chloroquine to treat malaria patients likely selects for ciprofloxacin resistance in E. coli . 7 It has been shown that two thirds of ESBL producers carry resistant determinants against quinolones, mainly in E. coli , 8 and therefore, MDR bacteria can emerge even in the absence of exposure to different antibiotics because co-selection mechanisms with chloroquine may favor the emergence of antibiotic resistance. Also within this issue, Angue and colleagues 9 reported that the rate of intestinal carriage of MDR bacteria among patients who have traveled abroad within the 6 months prior to being admitted at an intensive care unit (ICU) was higher (33%) than that of local patients with no traveling records (6.7%). In addition, the former group also showed higher acquisition of MDR (17%) when compared with the local patients (5.2%) after a secondary screening during the ICU stay in those patients with no detection during the admission screening. Such acquisition during the ICU stay most likely suggests the presence of a subpopulation of MDR Gram-negative bacteria that was not detected during the first screening and that was later enriched due to increased antibiotic selective pressure, therefore not being a “true” acquisition but rather a “revelation,” as already described. 10 The fact that chromogenic agar was used as the screening method instead of a more sensitive molecular method to detect the presence of the most frequent resistant determinants likely accounts for such phenomenon. Interestingly, among the risk factors associated with MDR carriage in patients abroad, diabetes mellitus and hospitalization abroad with antibiotic treatment were statistically significant. Among the three above-mentioned potential pathways for the global dissemination of MDR bacteria, international traveling is likely the most difficult to control, because food usually follows rigorous controls before being distributed at an international scale and migrant birds can have an impact on the dissemination of MDR bacteria in the environment but not so much directly on human beings. On the other hand, travelers returning from areas with a high endemicity of MDR bacteria that are further hospitalized in their country of origin are potential carriers of MDR bacteria, as shown by the two studies published within the present issue and previous reports. 11,–19 Therefore, they pose a real threat not only for the carriers themselves but also in terms of the potential spread of MDR bacteria inside the hospital, generating an outbreak as reported in Paris, France, where among 63 carbapenemase-producing Enterobacteriaceae events that occurred between 2004 and 2011, 87% involved patients with a link with cross-border exchanges. 20 Therefore, screening for MDR bacteria should be performed in all patients returning from high-endemic areas that are admitted at the hospital irrespective of whether they show the above-mentioned risks factors, because additional factors such as the nature of the trip, differences in personal hygiene practices, alimentary habits, and duration of stay may also contribute to carriage of MDR bacteria. In addition, the successful and rapid detection of potential carriers also plays an important role in further preventing the dissemination of MDR bacteria and in the decision as to whether a hospitalized patient should be isolated. In this sense, the use of chromogenic or selective screening media versus specific molecular test directly from rectal swabs or stool samples surely makes a difference, although the decision to use either method ultimately depends on the idiosyncrasy of each hospital and its resources. The author states that he has no conflicts of interest to declare.
No takes yet. Share an insight, caveat, or question.
Jordi Vilà (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: